Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000912282-25-000783
Filing Date
2025-07-21
Accepted
2025-07-21 12:59:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 3931
  Complete submission text file 0000912282-25-000783.txt   5459
Mailing Address 3230 W. COMMERCIAL BOULEVARD SUITE 180 FORT LAUDERDALE FL 33309
Business Address 3230 W. COMMERCIAL BOULEVARD SUITE 180 FORT LAUDERDALE FL 33309 416-861-2267
Flora Growth Corp. (Subject) CIK: 0001790169 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-93855 | Film No.: 251136589
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FLORA GROWTH CORP. 3405 SW 26TH TERRACE, SUITE C-1 FORT LAUDERDALE FL 33312
Business Address
Vaiman Dany (Filed by) CIK: 0001955467 (see all company filings)

Type: SCHEDULE 13D/A